Similar Search Results

Prescription behavior of physicians in the public and private sector

Jussila, Elina; Kotakorpi, Kaisa; Verho, Jouko - 2022

We analyze prescription behavior of physicians in the public and private sector. We study two major diseases for which … private sector physicians are more likely to prescribe the expensive medication. The result holds after controlling for … our cases, we further find that the same physicians prescribe different medication when working in different sectors …

Persistent link: https://www.econbiz.de/10013482204

Strategic interaction in the market for physician services : the treadmill effect in a fixed budget system

Benstetter, Franz; Wambach, Achim - 2001

We examine the strategic interaction in the market for physician services when the total budget for reimbursement is fixed. We show that this prospective payment system involves { compared to a fee-for-service remuneration system { a severe coordination problem, which potentially leads to the...

Persistent link: https://www.econbiz.de/10011398025

Introducing activity-based payment in the hospital industry : evidence from French data

Choné, Philippe; Evain, Franck; Wilner, Lionel; … - 2013

Many countries have reformed hospital reimbursement policies to provide stronger incentives for quality and cost …

Persistent link: https://www.econbiz.de/10009765047

Competition and physician behaviour : does the competitive environment affect the propensity to issue sickness certificates?

Brekke, Kurt R.; Holmås, Tor Helge; Monstad, Karin; … - 2017

Competition among physicians is widespread, but compelling empirical evidence on the impact on service provision is …

Persistent link: https://www.econbiz.de/10011734380

Health service gatekeepers

Malcomson, James - 2003

Incentive contracts for gatekeepers who control patient access to specialist medical services provide too weak incentives to investigate cost further when expected cost of treatment is greater than benefit. Making gatekeepers residual claimants with a fixed fee from which treat-ment costs must...

Persistent link: https://www.econbiz.de/10011511048

Public health care with waiting time : the role of supplementary private health care

Hoel, Michael; Sæther, Erik Magnus - 2001

We consider an economy where most of the health care is publicly provided,and where there is waiting time for several types of treatments. Privatehealth care without waiting time is an option for the patients in the publichealth queue. We show that although patients with low waiting costs...

Persistent link: https://www.econbiz.de/10011400300

Margins and market shares : pharmacy incentives for generic substitution

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2012

We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies' substitution...

Persistent link: https://www.econbiz.de/10009691207

Reference pricing, competition, and pharmaceutical expenditures : theory and evidence from a natural experiment

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2010

We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. First, we construct a vertical...

Persistent link: https://www.econbiz.de/10008749029

Supplementary private health insurance in selected countries : lessons for EU governments?

Gechert, Sebastian - 2009

A famous idea to maintain affordable health expenditures is to cut back statutory health insurance (SHI) to a basic insurance and to introduce supplementary private health insurance (PHI), permitted to cover the remaining benefits and to apply managed care mechanisms. The measure is supposed to...

Persistent link: https://www.econbiz.de/10003872288

Coinsurance vs. copayments : reimbursement rules for a monopolistic medical product with competitive health Iinsurers

Cremer, Helmuth; Lozachmeur, Jean-Marie - 2021

This paper studies a market for a medical product in which there is perfect competition among health insurers, while the good is sold by a monopolist. Individuals differ in their severity of illness and there is ex post moral hazard. We consider two regimes: one in which insurers use coinsurance...

Persistent link: https://www.econbiz.de/10012581345